Blood DNA Methylation Biomarkers of Post AcuteSequelae of SARS CoV 2 Infection (PASC)
SARS CoV 2 感染后急性后遗症的血液 DNA 甲基化生物标志物 (PASC)
基本信息
- 批准号:10730452
- 负责人:
- 金额:$ 81.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-05 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:2019-nCoVAcuteAcute respiratory failureAge FactorsBloodBlood specimenCOVID-19COVID-19 impactCOVID-19 patientCOVID-19 severityCOVID-19 survivorsCell SeparationCellsCessation of lifeChemicalsClassificationClinicalCognitiveCritical IllnessDNADNA MaintenanceDNA MethylationDNA methylation profilingDNA sequencingDataDevelopmentDimensionsDyspneaEnvironmental Risk FactorEpigenetic ProcessExhibitsFunctional disorderFutureGene ExpressionGene Expression RegulationGenomicsHospitalizationHospitalsImmuneIndividualInflammatoryIntegration Host FactorsLeukocytesLong COVIDLymphoidLymphoid CellMagnetismMeasuresMethylationMissionModificationMolecularMuscle WeaknessMyelogenousMyeloid CellsNational Heart, Lung, and Blood InstituteNatureOutcomeParticipantPatientsPatternPhenotypePopulationPositioning AttributePost-Acute Sequelae of SARS-CoV-2 InfectionPredispositionProcessPublic HealthPublishingRNARNA SequencesRecoveryRegulationReportingResearchResolutionSARS-CoV-2 infectionSamplingSensitivity and SpecificitySeverity of illnessSleep DisordersSubgroupTestingTimeTissuesTranscriptUnited States National Institutes of HealthUntranslated RNAacute infectionchromatin modificationclinical phenotypedisorder controlepigenetic regulationgenome-widehistone modificationindividual responseinfection burdeninorganic phosphateinstrumentlong-term sequelaelongitudinal analysismachine learning classificationmethylation biomarkermethylomemultiple omicsnovelpost SARS-CoV-2 infectionpost-COVID-19transcriptometranscriptome sequencingwhole genome
项目摘要
Project Summary: DNA 5'-C-phosphate-G-3' (CpG) methylation is a covalent epigenetic modification that
regulates gene expression and is highly sensitive to age and environmental factors. Critically ill patients exhibit
altered circulating blood DNA methylation profiles. We have recently reported a large scale methylome analysis
of COVID-19 in association with clinical outcomes, which suggests an epigenetic regulation of genes controlling
disease severity. Recent evidence indicates that many surviving COVID-19 patients develop long term
dysfunctions and the NIH-NHLBI has recently launched an initiative to elucidate the nature of Post-Acute
Sequelae of SARS-CoV-2 Infection (PASC). It is currently unknown if the rapid methylome regulation evoked by
acute illness persist after SARS-CoV-2 resolution. Such persistence could underpin long term sequela
associated with this condition. Because DNA methylation is a relatively stable DNA chemical modification that
could influence long-term gene expression profiles and given that we recently found that multiple regions
developed during acute illness persist differentially methylated one year after hospital discharge, we
hypothesize that COVID-19 infection leads to enduring DNA methylation abnormalities that remain after
resolution of acute illness in association with the post-COVID-19 clinical profile. In this application, we
plan to conduct whole genome DNA methylation and RNA sequencing of circulating leucocytes to establish sub
phenotypes of PASC, predict future PASC development in the acute COVID-19, and determine which circulating
leucocyte lineage contributes to that enduring methylome.
项目摘要:DNA 5'-C-磷酸G-3'(CpG)甲基化是一种共价表观遗传学修饰,
调节基因表达,对年龄和环境因素高度敏感。重病患者表现出
改变的循环血液DNA甲基化谱。我们最近报道了大规模的甲基分析
COVID-19与临床结果相关,这表明对控制基因的表观遗传调节
疾病的严重程度。最近的证据表明,许多幸存的共同19岁患者长期发展
功能障碍和NIH-NHLBI最近发起了一项计划,以阐明急性后的性质
SARS-COV-2感染(PASC)的后遗症。目前尚不清楚甲基组的快速调节是否由
SARS-COV-2分辨率后,急性疾病持续存在。这种持久性可能是长期后遗症的基础
与这种情况相关。因为DNA甲基化是一种相对稳定的DNA化学修饰
可能影响长期基因表达谱,鉴于我们最近发现多个区域
出院后一年,急性疾病期间开发的持续差异化甲基化,我们
假设COVID-19的感染导致持久的DNA甲基化异常,而在
急性疾病与COVID后-19临床特征有关。在此应用程序中,我们
计划进行整个基因组DNA甲基化和循环白细胞的RNA测序以建立亚
PASC的表型,预测急性共vid-19的未来PASC发育,并确定哪个循环
白细胞谱系有助于持久的甲基化体。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Reid Spencer Alisch其他文献
Unconventional translation of human LINE-1 ORF2.
人类 LINE-1 ORF2 的非常规翻译。
- DOI:
- 发表时间:
2004 - 期刊:
- 影响因子:0
- 作者:
Reid Spencer Alisch - 通讯作者:
Reid Spencer Alisch
Reid Spencer Alisch的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Reid Spencer Alisch', 18)}}的其他基金
Blood DNA Methylation Biomarkers of Alzheimer’s Disease and Postoperative Neurocognitive Disorder
阿尔茨海默病和术后神经认知障碍的血液 DNA 甲基化生物标志物
- 批准号:
10667556 - 财政年份:2022
- 资助金额:
$ 81.24万 - 项目类别:
Blood DNA Methylation Biomarkers of Alzheimer’s Disease and Postoperative Neurocognitive Disorder
阿尔茨海默病和术后神经认知障碍的血液 DNA 甲基化生物标志物
- 批准号:
10447364 - 财政年份:2022
- 资助金额:
$ 81.24万 - 项目类别:
Blood DNA Methylation Biomarkers of Alzheimer's Disease
阿尔茨海默病的血液 DNA 甲基化生物标志物
- 批准号:
10398174 - 财政年份:2020
- 资助金额:
$ 81.24万 - 项目类别:
Blood DNA Methylation Biomarkers of Alzheimer's Disease
阿尔茨海默病的血液 DNA 甲基化生物标志物
- 批准号:
10055220 - 财政年份:2020
- 资助金额:
$ 81.24万 - 项目类别:
Blood DNA Methylation Biomarkers of Alzheimer's Disease
阿尔茨海默病的血液 DNA 甲基化生物标志物
- 批准号:
10617233 - 财政年份:2020
- 资助金额:
$ 81.24万 - 项目类别:
Blood DNA Methylation Biomarkers of Alzheimer's Disease
阿尔茨海默病的血液 DNA 甲基化生物标志物
- 批准号:
10216168 - 财政年份:2020
- 资助金额:
$ 81.24万 - 项目类别:
相似国自然基金
阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
- 批准号:82302281
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
- 批准号:22304039
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
RNA甲基转移酶NSUN2介导SCD1 mRNA m5C修饰调控急性髓系白血病细胞铁死亡的机制研究
- 批准号:82300173
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于IRF5/MYD88信号通路调控巨噬细胞M1极化探讨针刀刺营治疗急性扁桃体炎的机制研究
- 批准号:82360957
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:地区科学基金项目
相似海外基金
The role of epigenetic regulator UHRF1 in stability of induced regulatory T-cell function during influenza A virus-induced lung injury
表观遗传调节因子 UHRF1 在甲型流感病毒诱导的肺损伤过程中诱导调节 T 细胞功能稳定性中的作用
- 批准号:
10389878 - 财政年份:2023
- 资助金额:
$ 81.24万 - 项目类别:
Development of an Oral Pan-Coronavirus Drug Cocktail
口服泛冠状病毒药物混合物的开发
- 批准号:
10714472 - 财政年份:2023
- 资助金额:
$ 81.24万 - 项目类别:
Function interactions between mitogen-activated protein kinases (MAPKs) and SARS-CoV-2
丝裂原激活蛋白激酶 (MAPK) 与 SARS-CoV-2 之间的功能相互作用
- 批准号:
10659904 - 财政年份:2023
- 资助金额:
$ 81.24万 - 项目类别:
MLL1 drives collaborative leukocyte-endothelial cell signaling and thrombosis after coronavirus infection
MLL1在冠状病毒感染后驱动白细胞-内皮细胞信号传导和血栓形成
- 批准号:
10748433 - 财政年份:2023
- 资助金额:
$ 81.24万 - 项目类别:
Natural model for evaluating within- and cross-species virus transmission
评估物种内和跨物种病毒传播的自然模型
- 批准号:
10735974 - 财政年份:2023
- 资助金额:
$ 81.24万 - 项目类别: